The permeability of the perilymphatic-endolymphatic interface for carb
oplatin was determined after lateral cerebral ventricle infusion of ra
dioactive carboplatin ine[1,1-cyclobutane-1-C-14-dicarboxylate]platinu
m) to rats. [C-14]sucrose, a similar weight molecule was used for comp
arison of the kinetics in the inner ear fluids. C-14-radioactivity was
measured in perilymph and endolymph. The rate of elimination of the t
racers from perilymph was equivalent indicating no difference in trans
port across the blood-perilymph barrier. The transport from perilymph
to endolymph was very restricted for both substances. The present stud
y indicates that the ototoxic effect of carboplatin cannot be explaine
d by a specific endolymphatic transport mechanism.